• Newsletter

    Reduce the Likelihood of Future Allergies

  • Reduce the Likelihood of Future Allergies

    Cow’s Milk Allergy (CMA) is among the most common food allergies in early childhood, with an estimated prevalence of 2% to 3%1. Infants with CMA often go on to present other allergic manifestations, a phenomenon known as the Allergic March. In fact, infants with food allergies may be 2–4 times more likely to have other allergies by 5 years of age1. However, a recent clinical study has found that feeding infants Nutramigen® LGG®* helps interrupt the Allergic March and reduces the likelihood of other allergic manifestations at 3 years of age1,†. Nutramigen LGG is approved in all Women, Infants and Children (WIC®) programs in the United States.

  • The Allergic March

    Infants with Cow’s Milk Allergy (CMA) often go on to have other allergic manifestations. For example, in a 5-year checkup of infants with CMA:

    • 75% had allergies to other foods2
    • 43% had allergic rhinitis2
    • 40% had asthma2
    • 21% had atopic dermatitis2

    The increased food allergy prevalence in children has an important economic effect, with significant direct costs for the healthcare system and even larger costs for families1.

    New Data! Fewer Allergy Challenges Later in Life

    Feeding Nutramigen® LGG®* to manage Cow’s Milk Allergy can have a positive impact on an infant’s future health. A recent clinical study found that infants fed Nutramigen LGG had a ~50% reduction in the likelihood of future allergic manifestations at 3 years1,†.

    Allergic manifistations combined at 3 years

    When allergic manifestations were assessed individually in the study, further exploratory analysis suggested that infants fed Nutramigen LGG also experienced:

    • 68% reduction in rhinoconjunctivitis1
    • 61% reduction in allergic urticaria1
    • 44% reduction in eczema1
    • 51% reduction in asthma1

    Fast Relief Now

    Nutramigen LGG is clinically proven to provide fast relief for infants with CMA by starting to manage colic in as early as the first feeding—with 90% of infants improving within 48 hours3,‡,§. It also significantly improves blood in stools of infants with CMA: In a clinical study, infants with CMA fed Nutramigen LGG had 0% blood in their stools after only 4 weeks of feeding4.

    More Infants Return to Cow’s Milk with Nutramigen LGG

    Plus, Nutramigen LGG can also help infants return to milk-based formula sooner than waiting to outgrow the allergy naturally. After 6 months of feeding Nutramigen LGG, 59% of infants could consume cow’s milk protein—181% more than infants fed Nutramigen without LGG5. By 12 months, 81% of infants fed Nutramigen LGG could consume cow’s milk protein, including drinking 1 cup of cow’s milk daily without an allergic response5.

    Cumulative at 12 Months

    Recommend Nutramigen LGG for infants with CMA—help them feel better fast now and have fewer allergy challenges later in life.

    Nutramigen LGG—Fast Relief NOW. Fewer Allergy Challenges LATER.

  • * LGG is a registered trademark of Valio Ltd.
    † Rhinoconjunctivitis, urticaria, eczema and asthma.
    ‡ When managing colic due to cow’s milk allergy.
    § Studied before the addition of DHA, ARA or LGG.

    References: 1. Canani RB et al. J Allergy Clin Immunol. 2017. doi:10.1016/j.jaci.2016.10.050. (In press). 2. Bishop JM et al. J Pediatr. 1990;116:862-867. 3. Lothe L et al. Pediatrics. 1989;83:262-266. 4. Baldassarre ME et al. J Pediatr. 2010;156:397-401. 5. Canani RB et al. J Allergy Clin Immunol. 2012;129:580-582. 6. Canani RB, email, April 23, 2012.

Newsletter Archive Downloads (PDF)

  • Intended for U.S. Healthcare Professionals Only
  • ©2004, 2017 Mead Johnson & Company, LLC. All Rights Reserved.